Japan’s MHLW grants priority review for PADCEV and KEYTRUDA combo in urothelial cancer

Pallavi Madhiraju- February 18, 2024 0

In a significant development in the fight against urothelial cancer, Astellas Pharma Inc. announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has awarded ... Read More